Diagnostic and Interventional Cardiology
Diagnostic and Interventional Cardiology is a specialized magazine designed for cardiologists and catheterization labs. It is published by Scranton Gillette Communications and primarily highlights interventional cardiology, which involves catheter-based techniques to treat structural heart issues. The magazine shares the latest news and advancements in this area, making it a respected source in the healthcare sector. In recognition of its quality, it received an award from the American Society of Healthcare Publication Editors in 2013.
Outlet metrics
Global
#571055
United States
#328122
Health/Health
#5821
Articles
-
Nov 18, 2024 |
dicardiology.com | Pamela Duncan
Nov. 16, 2024 Anthos Therapeutics, Inc.recently presented new data at the American Heart Association (AHA) Scientific Sessions from its AZALEA-TIMI 71 study that demonstrated the novel factor XI inhibitor abelacimab led to consistent and substantial reductions in bleeding for patients on or off antiplatelet (APT) therapy, as compared to rivaroxaban.
-
Nov 15, 2024 |
dicardiology.com | Melinda Taschetta-Millane |Dave Fornell
E-newsletter Subscription formWhich of the following FREE newsletters do you wish to receive?
-
Nov 7, 2024 |
dicardiology.com | Intra-Vascular Ultrasound |Dave Fornell
Oct. 28, 2024 — Cardiawave SA, developer of Valvosoft Non-Invasive Ultrasound Therapy (NIUT) device for treating severe symptomatic calcific aortic stenosis (CAS), announced that the device met the primary endpoint in its pivotal study and improved or stabilized heart failure symptoms for 80.5 percent of patients, substantially improving hemodynamics and patient quality of life six months after treatment.
-
Oct 24, 2024 |
dicardiology.com | Pamela Duncan
Oct. 24, 2024 – Royal Philips and Medtronic Neurovascular have announced a strategic advocacy partnership. Delivering timely stroke care is crucial to saving lives and reducing long-term disability. As leaders in stroke diagnosis and treatment, the two organizations are advocating on raising awareness around the potential health and economic benefits for patients, their families and societies of improving access to timely stroke diagnosis and treatment.
-
Oct 20, 2024 |
dicardiology.com | Dave Fornell
Earlier this year, Materialise, a global supplier of 3D printing software and services, acquired FEops, a Belgian company that develops AI-driven simulation technology to improve procedure efficiency and clinical outcomes for structural heart interventions. The acquisition will allow Materialise to expand its cardiovascular solutions with predictive simulation capabilities, advancing the personalized treatment of patients with heart diseases.
Contact details
Address
123 Example Street
City, Country 12345
Phone
+1 (555) 123-4567
Email Patterns
Website
http://dicardiology.comTry JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →